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carbipenems and fluorinated quinolones need clinical 
validation; however, in vitro susceptibility profile appears 
promising. 
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In eubacteria Escherichia coli and Bacillus subtilis, the 
glpTQ operon is involved in utilization of glycerol3- 
phosphate (G3P) as a carbon source, and the glpT and 
glpQ genes transcribe as a single unit. In Haemophilus 
influenzae, we have previously characterized the glpT 
and glpQ homologues encoding glycerol-3-phosphate 
permease and glycerophosphodiester phosphodiesterase, 
respectively. The protein encoded by glpQ is also called 
Protein D and is involved in pathogenesis. In this study, 
we analysed the glpTQ transcripts in one H. injluenzae 
type b (Hib) and one nontypeable (NTHi) strain, and 
characterized potential function of the 1.4 kb glpTQ 
intergenic region that exists in most Hib strains but not 
in NTHi strains. In Northern blot and RT-PCR analysis, 
the glpT and glpQ genes in the Hib strain transcribed 
separately, whereas a co-transcribed glpTQ was found in 
the NTHi strain. It suggests that the 1.4 kb glpTQ 
intergenic region in Hib strains partially blocks the 
glpTQ operon transcription. When an isogenic mutant 
strain where the 1.4 kb region was replaced with 
a kanamycin cassette in the chromosome of the wild- 
type strain was tested, the blockage of the glpTQ 
transcription disappeared. We therefore conclude that 
due to the existence of the 1.4 kb glpTQ intergenic 
region in Hib strains, the glpTQ operons between Hib 
and NTHi strains transcribed differently. Based on a 
much lower G+C content (26 %) of the 1.4 kb DNA 
coding region than an overall G+C content of 38 % for 
the H. influenzae genome, we speculate that the 1.4 kb 
region might have been acquired by lateral transfer from 
an organism with a lower G+C content. 
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Background: The aim of this open, uncontrolled study 
was to evaluate the reliability of IL for the treatment of 
microbiologically proven, uncomplicated CRBSI, in 
different categories of immunocompromised patients. 
Methods: IL is based on a daily intraluminal instillation 
of a pre-definite highly concentrated solution of 
antimicrobials into the colonized line, locked within the 
line for at least 12 hrs/day Then the solution is removed 
and the CVC eventually re-used. In our study locks 
were repeated along 14 days. Vancomycin or teicoplanin 
20 mg/ml were delivered for empirical locks, or in the 
presence of staphylococci, enterococci, micrococci and 
corynebacteria; amikacin 10 mg/ml or ciprofloxacin 2 
mg/ml for susceptible Gram-negative bacteria; tailored 
antimicrobials for Gram-negative with different patterns 
of chemosensitivity. Fungal CRBSI were excluded. 23 
patients, who had signs and symptoms of uncomplicated 
CRBSI, according to defined criteria, with AIDS (14) 
or haematological neoplasias (9) and carrying long-term 
central venous catheter (CVC) (tunnelled or totally im- 
plantable), were consecutively enrolled. Per protocol, 
they were all given locks plus systemic antimicrobial 
therapy during the first 48 hrs. After this time, once 
microbiological diagnosis had been proven, clinical 
reassessment was performed. If defervescence of fever 
occurred, the patient continued receiving IL alone or in 
combination with systemic therapy (same antimicrobials 
used for locks), according to the clinician’s decision. 
Results: Twelve underwent locks alone and 11 locks plus 
systemic therapy thereafter. 21/23 pts (91.3%) were 
cleared from infection and retained the line in place: 
12/12 in the IL arm and 9/11 in the IL plus systemic 
therapy arm, as of clinical and microbiological follow-up 
performed at 14 days after the completion of treatment. 
The only two failures occurred in the combined treatment 
arm and were due to polymicrobial infections (methi- 
cillin-resistant Staphylococcus aureus plus Gram-negative 
bacteria), treated with glycopeptide alone-based locks. 
Conclusions: This study, though limited, confirms that 
IL is an effective treatment option also for immuno- 
compromised patients. Furthermore IL alone seems to 
be at least as effective as IL plus systemic therapy in 
the treatment of uncomplicated CRBSI, for the high 
antimicrobial concentrations obtained directly within 
the site of infection; but it results also in negligible blood 
antimicrobial concentrations, thus limiting the risk of 
dose-dependent side-effects and making it appealing in 
pts with liver or renal impairment as well. 
Trends in spectrum and susceptibility patterns of 
pathogens causing bacteremia in pediatric febrile 
neutropenic oncologic patients (1998-2002) 
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Background: Prospective surveillance of resistant 
bacterial pathogens is an indispensable tool of quality 
control in pediatric oncology departments. 
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Objectives: To analyze trends in microbiologic spectrum 
and susceptibility patterns of pathogens causing 
bacteremia in pediatric febrile neutropenic oncologic 
patients treated with two different empirical antibiotic 
regimens (ceftazidime (CAZ) plus gentamacin (GNT) 
during 1998-1999 and piperacillin/tazobactam (TAZ) 
plus GNT during 2000-2002). 
Methods: A retrospective analysis of all bacteremias 
occurring in patients with fever and neutropenia 
admitted to the Pediatric Oncology Unit between 
l/1/1998 and 281212002. 
Results: 81 bacteremia episodes were diagnosed in 40 
patients. The most common oncologic diagnoses were 
leukemia (48%) lymphoma (15%) and bone and soft 
tissue malignancies (18%). Overall, 130 (33 and 97 
during 1998-1999 and 2000-2002, respectively) organisms 
were isolated: 84 (65%) Gram negative (GmN), 39 
(30%) Gram positive (GmP) and 7 (55) fungi. Entero- 
batter spp. decreased from 18% to 6% (p=O.O5) and 
KZebsieZEa spp. increased from 9% to 15% from 
1998-1999 to 2000-2002. GmP organisms increased 
from 24% to 31% (p=O.O7) from 1998-1999 to 
2000-2002: S. epidermidis increased from 6% to 13%, 
Streptococcus spp. from 6% to 11% while S. aureus 
decreased from 6% to 0%. There were no MRSA-due 
bacteremias. 9 (21%) of the 42 E. coli, KZebsieZZu and 
Entrobacter spp isolates were resistant to all cephalo- 
sporins and to ampicillin/ clavulanate; 7/9 (78%) were 
isolated during 2000-2002. 9/9, 3/3, 3/9 (33%) and 8/9 
(89%) of these isolates were susceptible to imipenem, 
TAZ, GNT and ciprofloxacin, respectively. Overall 
pathogen susceptibility to TAZ (30 organisms tested) 
was higher compared to CAZ (76 isolates)-(94% vs. 
82%, P=O.l). 22/24 (92%) and 43/54 (78%) of GrN 
organisms isolated during 2000-2002 were susceptible to 
TAZ and CAZ, respectively (P=O.2). 
Conclusions: (1) An increase in the number of GmP 
organisms was recorded during the last 2 years; (2) An 
increase in the number of multi-drug resistant E. coli, 
KZebsieZZa and Enterobacter spp. occurred during the last 
2 years; (3) The initial empiric therapy with TAZ was 
more appropriate than CAZ in the coverage of most of 
the pathogens causing bacteremia. 
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with long-term central venous catheters at Instituto 
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Objective: Measurement of Incidence Laboratory 
confirmed bloodstream infection (BSI) in children with 
long-term central venous catheters (LT-CVC). 
Methods: Cohort of 745 LT-CVCs inserted in children, 
between January 1995 and July 2001, (main diagnosis, 
date of insertion, date of removal, LT-CVC type, indica- 
tion for removal) and crosslink with blood culture data 
bank (date of colection, species isolated). Any positive 
blood culture with a common pathogens (such as 
S. aureus, Gram-negative bacilli, and Cundida sp) were 
considered a catheter renal infection (CRI). Common 
skin contaminants (coagulase-negative staphylococci, 
diphtheroids, Bacillus sp., or Micrococcus sp.) isolated 
from two or more samples and associated with specific 
treatment or catheter removal, were considered a CRI. 
Results: One or more BSI episodes were observed in 
52% of LT-CVC. A total of 488 BSI episodes in 194.730 
catheters-days (2.51 episodes/l.000 CVC-days). Hickman 
or Hickman-Broviac catheters had a higher incidence of 
BSI (3.06/1000 CVC-days) when compared with Port 
catheters (1.50/1000 CVC-days; OR=2,04; PcO.05). 
Pediatric patients with hematological neoplasia, showed 
a higher BSI incidence than children with solid tumors. 
(4.88/1000 versus 1.82/1000 CVC-days, OR=2,68; 
P<0,05).The mean time to the first BSI episode was 124 
days (median=75 days). 
Conclusion: The incidence of BSI in children with LT- 
CVC varies according to the type of catheter and the 
type of neoplasia being treated. 
Methicillin-resistant StqhyZococcus aweus (MRSA) 
in a general hospital-a ten-year review 
M. Jovanovic, S. Pavic, G. Kovacevic, M. Komazec 
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Objectives: We reviewed new patient episodes of 
colonization/ infection and new episodes of bacteremia 
caused by MRSA (methicillin-resistant Staphylococcus 
aureus). We investigated the trend of incidence of MRSA 
in General Hospital Uzice. 
Methods: A total of 2255 MRSA were isolated from 
various clinical samples from January 1991 to December 
2001. 
Results: The annual rates of MRSA among S. aureus 
increased during the study period from 23.05% in 1991 
to 65.11% in 2001 (linear trend of growth, ~~0.01). The 
yield of MRSA was the highest from wounds/ulcers/skin 
swabs accounting for 83.28% while it was 1.86% from 
blood cultures. The overall incidence of colonization/ 
infection with MRSA was 1.12/100 (range 0.57-1.52) 
admissions and 0.98/1000 (range 0.50-1.29) patient-days. 
Conclusions: The incidence of MRSA in our hospital is 
high, average 42.75% and has linear trend of growth. 
Prevalence of resistant Gram-negative bacilli (GNB) 
in nursing homes (NH) 
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Ceftazidime resistance (CTZR) among GNB is in- 
creasing in hospitals worldwide and may be a marker for 
